Products for Research Use Only

Phospho-signaling analysis

Phosphorylated Antibodies for Measuring Protein Activation and Signaling

Phosphorylated antibodies, also called phospho-specific antibodies, recognize a protein only when a defined serine, threonine or tyrosine residue is phosphorylated. Researchers use them to monitor pathway activation, compare treatment responses and examine dynamic signaling events in cells and tissues. Compare products by target protein, phosphorylation site, residue number, clone, species reactivity, validated application, sample preparation requirements and pack size.

Product catalog

Browse Phosphorylated Antibodies

Compare product names, catalog numbers, available sizes, pricing, and product specifications.

What are phospho-specific antibodies?

Phospho-specific antibodies are designed to recognize an epitope containing a phosphorylated amino-acid residue while showing limited recognition of the corresponding unmodified sequence. They can distinguish activation states that a total-protein antibody cannot resolve. Accurate target-site naming is essential because one protein may contain several phosphorylation sites with different functions and regulation.

These antibodies are used in Western blotting, phospho-flow cytometry, immunofluorescence, immunohistochemistry, immunoprecipitation and pathway-focused assays. Researchers commonly compare stimulated and unstimulated samples or evaluate changes after inhibitors, gene modification and time-course treatments. Because phosphorylation can change rapidly, sample collection and preservation are central to assay reliability.

Phosphatase activity, delayed processing, unsuitable lysis buffers and repeated freeze-thaw cycles can reduce phosphorylation before measurement. Researchers should confirm the exact residue, expected molecular weight and pathway response, and use total-protein or loading controls for context. A phospho-antibody signal represents recognition of the modified epitope, not automatically the activity of the entire pathway.

Buying and selection guide

How to choose a phosphorylated antibody

Match the exact phosphorylation site and experimental method, then design sample handling to preserve the modification from collection through detection.

01

Verify the residue and numbering

Confirm the protein name, amino-acid residue and sequence numbering system because isoforms and species may use different positions.

02

Check modified versus total recognition

Review evidence that the antibody preferentially detects the phosphorylated epitope and consider a matched total-protein antibody for comparison.

03

Preserve phosphorylation

Use rapid processing, cold conditions and appropriate phosphatase inhibitors based on the sample and protocol.

04

Confirm pathway controls

Include a known activator or stimulated sample and, when relevant, a phosphatase treatment or pathway inhibitor as controls.

05

Match fixation and lysis

Select sample preparation compatible with the application because harsh treatment can destroy the modification or change epitope accessibility.

06

Normalize carefully

Interpret phospho-signal relative to total target, loading controls, cell number or another justified reference rather than raw intensity alone.

Frequently asked questions about phosphorylated antibodies

These questions address phospho-site selection, sample preservation, controls, normalization and troubleshooting in signaling experiments.

What does a phospho-specific antibody detect?

It detects an epitope containing a defined phosphorylated serine, threonine or tyrosine residue. The antibody is intended to distinguish the modified form from the unphosphorylated sequence. Researchers should confirm the exact residue and protein isoform because antibodies against different sites on the same protein answer different biological questions.

What is the difference between a phospho-antibody and a total-protein antibody?

A phospho-antibody measures one phosphorylated form of the protein, while a total-protein antibody is intended to detect the target regardless of that modification. Using both can show whether the phospho-signal changed because phosphorylation altered or because the overall amount of the protein changed.

Why did my phospho-signal disappear during sample preparation?

Phosphatases can remove phosphate groups rapidly after cells or tissues are collected. Delayed processing, warm conditions, missing inhibitors or repeated freeze-thaw cycles may reduce the signal. Process samples quickly, keep them cold when appropriate and use a lysis system designed to preserve phosphorylation.

How do I validate a phospho-specific antibody?

Compare conditions expected to increase and decrease phosphorylation, such as stimulated versus unstimulated samples or inhibitor-treated controls. Phosphatase treatment can provide additional evidence when compatible with the assay. Also verify the expected molecular weight and compare the phospho-signal with total target protein.

Can phosphorylation-site numbering differ between products?

Yes. Residue numbering may vary because of species differences, precursor sequences, mature proteins or alternative isoforms. Compare the immunogen sequence and surrounding residues rather than relying only on the number. Confirm that the antibody's recognized sequence exists in the exact species and isoform being studied.

Why do I see several bands with a phospho-antibody?

Multiple bands may reflect isoforms, modified forms, degradation, related proteins or nonspecific recognition. Check the expected molecular weight, use positive and negative pathway controls and optimize antibody dilution and washing. Target loss through knockout or knockdown can help identify the specific band when available.

How should phospho-flow samples be fixed and permeabilized?

Use conditions validated for the target and antibody because signaling states can change rapidly and some permeabilization methods damage epitopes or fluorophores. Fix samples at a defined time after stimulation, keep processing consistent and include unstimulated and stimulated controls for every experiment.

Does a stronger phospho-signal always mean the pathway is more active?

Not necessarily. The signal reflects one phosphorylation site and may be influenced by total protein abundance, cell composition, sample handling and assay saturation. Some phosphorylation events inhibit rather than activate proteins. Interpret the result using known site biology, total-protein controls and additional pathway measurements.